GE Healthcare Technologies, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US36266G1076
USD
61.04
0.04 (0.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
5,131.00
5,698.00
5,143.00
5,007.00
4,777.00
5,319.00
4,863.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,131.00
5,698.00
5,143.00
5,007.00
4,777.00
5,319.00
4,863.00
Raw Material Cost
3,175.00
3,430.00
3,151.00
3,075.00
2,781.00
3,065.00
2,877.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
134.00
123.00
123.00
120.00
117.00
126.00
134.00
Selling and Distribution Expenses
1,028.00
1,045.00
1,003.00
1,003.00
983.00
1,006.00
962.00
Other Expenses
21.10
20.00
16.90
18.20
22.70
21.80
18.20
Total Expenditure (Excl Depreciation)
4,548.00
4,798.00
4,446.00
4,380.00
4,108.00
4,415.00
4,155.00
Operating Profit (PBDIT) excl Other Income
583
900
697
627
669
904
708
Other Income
118.00
100.00
96.00
77.00
99.00
151.00
115.00
Operating Profit (PBDIT)
854.00
1,146.00
942.00
851.00
904.00
1,195.00
966.00
Interest
134.00
123.00
123.00
120.00
117.00
126.00
134.00
Exceptional Items
-62.00
-56.00
-27.00
28.00
40.00
-95.00
-33.00
Gross Profit (PBDT)
1,956.00
2,268.00
1,992.00
1,932.00
1,996.00
2,254.00
1,986.00
Depreciation
153.00
146.00
149.00
147.00
136.00
140.00
143.00
Profit Before Tax
505.00
820.00
643.00
613.00
692.00
834.00
658.00
Tax
94.00
219.00
179.00
113.00
104.00
96.00
168.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
389.00
589.00
446.00
486.00
564.00
721.00
471.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
389.00
589.00
446.00
486.00
564.00
721.00
471.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
22.00
13.00
18.00
14.00
24.00
17.00
19.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
411.00
602.00
464.00
500.00
588.00
738.00
490.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
10,668.00
10,379.00
9,993.00
9,713.00
9,188.00
8,447.00
8,317.00
Earnings per share (EPS)
0.85
1.29
0.98
1.06
1.23
1.57
1.02
Diluted Earnings per share
0.85
1.29
0.98
1.06
1.23
1.57
1.02
Operating Profit Margin (Excl OI)
11.36%
15.8%
13.55%
12.52%
14.0%
17.0%
14.56%
Gross Profit Margin
12.82%
16.95%
15.4%
15.18%
17.33%
18.31%
16.47%
PAT Margin
7.58%
10.34%
8.67%
9.71%
11.81%
13.56%
9.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.41% vs 2.73% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -30.10% vs 51.55% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -8.57% vs 6.20% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 14.53% vs -4.10% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of GE Healthcare Technologies, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
5,131.00
1,798.00
3,333.00
185.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,131.00
1,798.00
3,333.00
185.37%
Raw Material Cost
3,175.00
848.00
2,327.00
274.41%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
134.00
24.00
110.00
458.33%
Selling and Distribution Expenses
1,028.00
458.00
570.00
124.45%
Other Expenses
21.10
9.30
11.80
126.88%
Total Expenditure (Excl Depreciation)
4,548.00
1,423.00
3,125.00
219.61%
Operating Profit (PBDIT) excl Other Income
583.00
375.00
208.00
55.47%
Other Income
118.00
31.00
87.00
280.65%
Operating Profit (PBDIT)
854.00
473.00
381.00
80.55%
Interest
134.00
24.00
110.00
458.33%
Exceptional Items
-62.00
-18.00
-44.00
-244.44%
Gross Profit (PBDT)
1,956.00
950.00
1,006.00
105.89%
Depreciation
153.00
67.00
86.00
128.36%
Profit Before Tax
505.00
364.00
141.00
38.74%
Tax
94.00
59.00
35.00
59.32%
Provisions and contingencies
0
0
0.00
Profit After Tax
389.00
305.00
84.00
27.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
389.00
305.00
84.00
27.54%
Share in Profit of Associates
0
0
0.00
Minority Interest
22.00
0.00
22.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
411.00
305.00
106.00
34.75%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
10,668.00
6,908.00
3,760.00
54.43%
Earnings per share (EPS)
0.85
1.07
-0.22
-20.56%
Diluted Earnings per share
0.85
1.07
-0.22
-20.56%
Operating Profit Margin (Excl OI)
11.36%
20.86%
0.00
-9.50%
Gross Profit Margin
12.82%
23.97%
0.00
-11.15%
PAT Margin
7.58%
16.96%
0.00
-9.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 513.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -9.95% vs 10.79% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.41% vs 2.73% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 41.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -31.73% vs 29.74% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -30.10% vs 51.55% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 73.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -29.64% vs 23.64% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -8.57% vs 6.20% in Mar 2025

Quarterly - Interest
Interest 13.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.94% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.53% vs -4.10% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.36%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025